This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Cytomx Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Christopher Kemball: Innovator in Polypeptide Research
Introduction
Christopher Kemball is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides. His work is instrumental in advancing therapeutic options for various medical conditions.
Latest Patents
Kemball holds a patent for "Single-and Multi-Chain Polypeptides That Bind Specifically to CD3 Epsilon." This innovation showcases his expertise in creating targeted therapies that can enhance immune responses.
Career Highlights
Currently, Christopher Kemball is employed at CytomX Therapeutics, Inc., where he continues to push the boundaries of scientific research. His role at the company allows him to collaborate with other talented professionals in the field.
Collaborations
Some of his coworkers include Pia Challita-Eid and Rene Hubert, who contribute to the innovative environment at CytomX Therapeutics, Inc. Their collective efforts aim to develop groundbreaking therapies that can improve patient outcomes.
Conclusion
Christopher Kemball's work in polypeptide research exemplifies the impact of innovation in biotechnology. His contributions are paving the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile